What are the diagnostic criteria for HELLP (Hemolysis, Elevated Liver enzymes, Low Platelet count) syndrome in pregnant women, particularly those with a history of preeclampsia or hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HELLP Syndrome Diagnostic Criteria

HELLP syndrome is diagnosed by the presence of three essential laboratory findings: hemolysis (confirmed by peripheral blood smear showing microangiopathic changes, elevated LDH, or low haptoglobin), elevated liver enzymes (AST/ALT significantly above normal), and thrombocytopenia with platelets below 100,000/mm³, after excluding other causes of these abnormalities. 1, 2

Core Diagnostic Components

Hemolysis Criteria

  • Peripheral blood smear must demonstrate microangiopathic hemolytic anemia with schistocytes and fragmented red blood cells 3
  • Elevated indirect bilirubin levels (may be up to 18 µmol/L or higher) 3
  • Low serum haptoglobin levels indicating intravascular hemolysis 1
  • Elevated lactate dehydrogenase (LDH) >295 U/L, which reflects both hemolysis extent and hepatic dysfunction 3, 4

Elevated Liver Enzymes

  • Aspartate aminotransferase (AST) >200 U/L (normal range 0-40 U/L) 3
  • Alanine aminotransferase (ALT) >159 U/L (normal range 0-45 U/L) 3
  • AST, ALT, LDH, and total bilirubin are the most useful markers for disease progression 5
  • The degree of liver enzyme elevation correlates with adverse maternal outcomes and necessitates urgent intervention 5

Thrombocytopenia

  • Platelet count below 100,000/mm³ is the threshold for diagnosis 5, 1, 2
  • Severe thrombocytopenia (<50,000/mm³) indicates active disease with significant maternal risk 5
  • The degree of thrombocytopenia directly correlates with liver dysfunction severity and predicts adverse maternal outcomes 5
  • Platelet count is one of the two most important clinical tools for disease assessment (along with LDH) 4

Associated Clinical Features

Common Presenting Symptoms

  • Right upper quadrant or epigastric pain occurs in 65% of symptomatic patients and should immediately trigger imaging to rule out subcapsular hematoma or hepatic rupture 5, 6
  • Nausea, vomiting, and gastrointestinal symptoms 3
  • Hypertension (arterial pressure may progress from 130/80 to 160/95 mm Hg or higher) 3
  • Proteinuria and peripheral edema (though these may be absent initially) 3, 2

Coagulation Studies

  • Prothrombin time and activated partial thromboplastin time are typically normal 3
  • Fibrinogen concentration remains normal 3
  • Elevated fibrin degradation products (>80 µg/L, normal <10 µg/L) indicate microangiopathic process 3

Critical Diagnostic Pitfalls

Recognition Challenges

  • HELLP syndrome may occur when usual clinical findings of severe preeclampsia are absent, leading to misdiagnosis with nonobstetric conditions 2
  • Up to 30% of HELLP cases occur or worsen within 48 hours postpartum, requiring vigilant monitoring even after delivery 7, 5
  • Delayed or missed diagnosis is life-threatening for both mother and child 6

Laboratory Monitoring Requirements

  • Obtain complete blood count with platelets, comprehensive metabolic panel, LDH, and coagulation studies 7
  • Continue laboratory monitoring every 6-12 hours for at least 24-48 hours postpartum 7, 5
  • Persistent epigastric pain with worsening liver enzymes mandates immediate abdominal imaging (ultrasound or CT) to exclude subcapsular hematoma or hepatic rupture 7, 5

Disease Severity Assessment

High-Risk Features Requiring Immediate Action

  • Severe thrombocytopenia (<50,000/mm³) with persistent right upper quadrant pain increases risk of hepatic hematoma or rupture 7
  • Progressive thrombocytopenia and persistent symptoms beyond 5 days postpartum may indicate ongoing disease activity or hepatic complications 7
  • Maternal mortality ranges from 2-24% with this syndrome, emphasizing the need for aggressive management 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

HELLP syndrome--a pregnancy disorder with poor prognosis.

Nepal Medical College journal : NMCJ, 2008

Guideline

Management of HELLP Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Obstetric management of patients with HELLP syndrome].

Zeitschrift fur Geburtshilfe und Perinatologie, 1993

Guideline

Resolution Timeline for Transaminitis After Pre-eclampsia and HELLP Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the diagnostic criteria for Hellp (Hemolysis, Elevated Liver enzymes, and Low Platelet count) syndrome?
What are the diagnosis and treatment of HELLP (Hemolysis, Elevated Liver enzymes, and Low Platelet count) syndrome?
What are the diagnostic criteria and management for HELLP (Hemolysis, Elevated Liver enzymes, and Low Platelet count) syndrome?
What is the most likely diagnosis for a 38-year-old pregnant woman at 31 weeks gestation, presenting with severe epigastric pain, vomiting, jaundice, impaired renal function, thrombocytopenia, anemia, and elevated liver enzymes?
What is the management for a postpartum patient developing symptoms of HELLP (Hemolysis, Elevated Liver enzymes, and Low Platelet count) syndrome without prior pre-eclampsia or HELLP syndrome?
What are the management options for a patient with plantar fasciitis?
What are the safety and efficacy considerations for using alteplase (tissue plasminogen activator) in patients with acute ischemic stroke who have been on prior antiplatelet therapy?
What does a 13 mm raised reaction to the Mantoux (Tuberculin) test indicate?
What is the management and treatment approach for a patient with Multiple Endocrine Neoplasia type 1 (MEN1) syndrome who is at risk of developing multiple endocrine tumors?
What are the management options for a patient with respiratory alkalosis, possibly due to hyperventilation, anxiety, or underlying medical conditions such as salicylate toxicity or sepsis?
What is the management approach for a patient with community-acquired pneumonia (CAP) at high risk for developing pneumothorax?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.